Stephens Downgrades Bio-Techne (TECH) to Equal Weight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/28/2026
- Wall Street ends mixed as investors focus on tech earnings
- NVIDIA’s rising CDS the talk of Wall Street amid circular financing fears
- U.S. chip stocks extend losses on AI financing, China competition fears
- Tesla to buy power from Arizona solar project
- Why BofA says July Fed rate hike would be "unprecedented"
- Visa (V) To Cut 7% Of Its Workforce, Totaling About 2,600 Jobs - Bloomberg
- BTIG Upgrades Outlook Therapeutics Inc. (OTLK) to Buy
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Carpenter Technology CEO Brian Malloy passes; Tony Thene returns as CEO
- Applied Digital (APLD) Tops Q4 EPS by 23c, Revenue Beats
Janney Capital Upgrades Bio-Techne (TECH) to Neutral
October 28, 2015 12:53 PM EDTJanney Capital upgraded Bio-Techne (NASDAQ: TECH) from Buy to Neutral with a price target of $100.00 (from $118.00).
For an analyst ratings summary and ratings history on Bio-Techne click here. For more ratings news on Bio-Techne click here.
Shares of Bio-Techne closed at $95.94 yesterday.
... MoreBio-Techne (TECH) Misses Q1 EPS by 6c
October 28, 2015 7:06 AM EDTBio-Techne (NASDAQ: TECH) reported Q1 EPS of $0.79, $0.06 worse than the analyst estimate of $0.85. Revenue for the quarter came in at $12.4 million versus the consensus estimate of $116.4 million.
For earnings history and earnings-related data on Bio-Techne (TECH) click here.
... More